Susan Morrison - Tandem Diabetes Insider

Tandem Diabetes Care Inc -- USA Stock  

USD 2.43  0.02  0.83%

Chief Admin. Officer

Susan M. Morrison serves as Chief Administrative Officer at Tandem Diabetes Care, Inc. since September 2013. From April 2013 until September 2013, she served as our Vice President, Human Resources, Corporationrationrate and Investor Relations. Ms. Morrison served as our Director, Corporationrationrate and Investor Relations, from January 2009 to March 2013, and was our Director, Corporationrationrate Services from November 2007 to December 2008. Prior to joining us, Ms. Morrison held various positions in Corporationrationrate and Investor Relations at Biosite from August 2003 through November 2007
Age: 36  Executive Since 2013      
Morrison holds a B.A. in Public Relations from Western Michigan University.

Susan Morrison Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (46.76) % which means that it has lost $46.76 on every $100 spent on asset. This is way below average.
The company currently holds 75.6 M in liabilities with Debt to Equity (D/E) ratio of 8.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Tandem Diabetes Care Inc has Current Ratio of 1.86 which is within standard range for the sector.

Entity Summary

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California. Tandem Diabetes operates under Medical Instruments Supplies classification in USA and traded on NASDAQ General Markets exchange. It employs 591 people.Tandem Diabetes Care Inc (TNDM) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 591 people. Tandem Diabetes is listed under Medical Equipment category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Tandem Diabetes Care Inc to your portfolio

Top Management

Tandem Diabetes Care Leadership Team
Brian Hansen, President, MBA
Fred Cohen, Director
Susan Morrison, Executive
Lori Gildea, President, MBA
Howard Greene, Director, MBA
Christopher Twomey, Director
Henry Anhalt, Director
Edward Cahill, Director
Lonnie Smith, Chairman, MBA
John Cajigas, CFO
Dick Allen, Chairman, MBA
David Berger, Executive
Jesse Treu, Director, Ph.D
Douglas Roeder, Director
Leigh Vosseller, President
John Sheridan, COO, MBA
Kim Blickenstaff, CEO, MBA
Robert Anacone, EVP

Stock Performance

Tandem Diabetes Performance Indicators